v3 Template
A
Addex Therapeutics
Pharmaceuticals/Healthcare
Geneva, Switzerland
Founded
--
Employees
--
Total Funding
$22.4M
Funding Rounds
6
Last Funding
2025-12-11
About Addex Therapeutics
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of novel orally available small molecule drugs known as allosteric modulators for neurological disorders.
Products & Services
Dipraglurant (mGlu5 NAM):Targeted for Post-Stroke and Traumatic Brain Injury (TBI) recovery.
ADX71149 (mGlu2 PAM):Under research and development for undisclosed indications.
GABAB PAM - Substance Use Disorder:Focused on treatment for substance use disorders.
GABAB PAM - Chronic Cough:Developed for the treatment of chronic cough.
Specialties
Allosteric Modulators
Neurological Disorders
Small Molecule Drugs
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: ATM Offering T: - FT: ATM Offering |
A: 3300000 MR: - FA: up to $3.3 million FAN: 3300000 |
D: 2025-12-11 FD: 2025-12-11 |
1 investors |
| 2 |
RT: At-the-Market Offering T: - FT: At-the-Market Offering |
A: 2100000 MR: - FA: up to $2.1 million FAN: 2100000 |
D: 2024-01-31 FD: 2024-01-31 |
1 investors |
| 3 |
RT: Grant T: - FT: Grant |
A: 4000000 MR: - FA: €4 million FAN: 4000000 |
D: 2023-09-20 FD: 2023-09-20 |
1 investors |
| 4 |
RT: Collaboration Funding T: - FT: Collaboration Funding |
A: 2970000 MR: - FA: CHF 2.7 million FAN: 2970000 |
D: 2023-08-03 FD: 2023-08-03 |
1 investors |
| 5 |
RT: Equity T: - FT: Equity |
A: 5000000 MR: - FA: $5.0 million FAN: 5000000 |
D: 2023-04-05 FD: 2023-04-05 |
1 investors |
| 6 |
RT: Equity Financing T: - FT: Equity Financing |
A: 5000000 MR: - FA: 5.0 million FAN: 5000000 |
D: 2023-04-03 FD: 2023-04-03 |
1 investors |
ATM Offering
Latest
2025-12-11
$3.3M
1 investor (Pro only)
At-the-Market Offering
2024-01-31
$2.1M
Grant
2023-09-20
$4.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Addex Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- addextherapeutics.com
- Industries
- Pharmaceuticals/Healthcare
- Locations
- Geneva, Switzerland
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro